Sequent Scientific Company Description
Sequent Scientific Limited operates in the veterinary healthcare business in Europe, Asia, and internationally.
The company provides animal health active pharmaceutical ingredients (APIs) formulations in the areas of antihelmentic, anti-parasites, antiprotozoal, NSAID, anti-bacterial, phosphorus supplement, beta agonist, analgesic, antimetic, anti- allergic, and congestive heart failure.
It also offers analytical services; and finished dosage formulations, and VET formulation. The company was formerly known as PI Drugs & Pharmaceuticals Ltd. and changed its name to Sequent Scientific Limited in October 2009.
The company was incorporated in 1985 and is headquartered in Mumbai, India. Sequent Scientific Limited is a subsidiary of CA Harbor Investments.
Country | India |
Founded | 1985 |
Industry | Drug Manufacturers - Specialty & Generic |
Sector | Healthcare |
Employees | 1,244 |
CEO | Rajaram Narayanan |
Contact Details
Address: Dosti Pinnacle Mumbai, 400604 India | |
Phone | 91 22 4111 4777 |
Website | sequent.in |
Stock Details
Ticker Symbol | SEQUENT |
Exchange | National Stock Exchange of India |
Fiscal Year | April - March |
Reporting Currency | INR |
ISIN Number | INE807F01027 |
SIC Code | 2834 |
Key Executives
Name | Position |
---|---|
Rajaram Narayanan | MD, Chief Executive Officer and Director |
Saurav Bhala | Chief Financial Officer |
Phillip Trott | Assoc. Vice President, Head of Legal and Chief Risk Officer |
Yoshita Vora | Company Secretary and Compliance Officer |
Vedprakash Ragate | Executive Director |
Ramesh Kumar Pillai | Corporate Vice President of Ra Qa and Technical Services |
Ravi Nair | Executive Vice President of Human Resources and Administration |
Abhishek Singhal | Head of Investor Relations |
Prasad Lad | Vice President of Human Resources and Administration |